In a report released yesterday, Stephen Baxter from Wells Fargo maintained a Hold rating on Cardinal Health (CAH – Research Report), with a ...

Morgan Stanley analyst Erin Wright maintained a Buy rating on Cardinal Health (CAH – Research Report) today and set a price target of $136.00.

Cardinal Health, Inc. CAH is scheduled to report fiscal second-quarter 2025 results on Jan. 30, before the opening bell. In ...

In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe ...

Cardinal Health gets downgraded to a hold, from my buy rating last February, agreeing with the Seeking Alpha quant system rating. While macro-level demand for medical supplies is expected to keep ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Cardinal Health (CAH) is a stock that can certainly grab the ...

Cardinal Health prepares to enter direct ... billion acquisition of Advanced Diabetes Supply Group of Carlsbad, California, a distributor of at-home medical supplies for managing diabetes.

Compared to the Medical - Dental Supplies industry's P/E of 17.9X, shares of Cardinal Health are trading at a forward P/E of 15.5X. CAH also has a PEG Ratio of 1.5, a Price/Cash Flow ratio of 11 ...

Cardinal Health Inc (CAH) stock saw a decline, ending the day at $127.73 which represents a decrease of $-3.00 or -2.29% from the prior close of $130.73. The stock opened at $130.84 and touched a low ...

Dublin City Schools is withdrawing from an agreement to buy Cardinal Health’s headquarters for $37 million to serve as a high ...

Cardinal Health Inc. hit a new 52-week high, surpassing its previous peak of $129.68, which the company achieved on January ...